Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer

Modi, S; Jacot, W; Yamashita, T; Sohn, J; Vidal, M; Tokunaga, E; Tsurutani, J; Ueno, NT; Prat, A; Chae, YS; Lee, KS; Niikura, N; Park, YH; Xu, BH; Wang, XJ; Gil-Gil, M; Li, W; Pierga, JY; Im, SA; Moore, HCF; Rugo, HS; Yerushalmi, R; Zagouri, F; Gombos, A; Kim, SB; Liu, Q; Luo, T; Saura, C; Schmid, P; Sun, T; Gambhire, D; Yung, LT; Wang, YB; Singh, J; Vitazka, P; Meinhardt, G; Harbeck, N; Cameron, DA

Modi, S (通讯作者)，Mem Sloan Kettering Canc Ctr, Montpellier, France.;Modi, S (通讯作者)，Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10065 USA.

NEW ENGLAND JOURNAL OF MEDICINE, 2022; 387 (1): 9

Abstract

BACKGROUND Among breast cancers without human epidermal growth factor receptor 2 (HER2) amplification, overexpression, or both, a large proportion exp......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索